首页> 美国卫生研究院文献>other >Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Survival and Metastasis for Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization

【2h】

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Survival and Metastasis for Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization

机译：中性粒细胞与淋巴细胞和血小板与淋巴细胞的比值作为经肝动脉化疗栓塞术后复发性肝细胞癌生存和转移的预测指标

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PurposeTo evaluate whether neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) predict survival and metastasis in patients after transarterial chemoembolization (TACE) for recurrent hepatocellular carcinoma (RHCC).

机译：目的评估中性粒细胞与淋巴细胞之比（NLR）和血小板与淋巴细胞之比（PLR）是否可预测经肝动脉化疗栓塞（TACE）治疗复发性肝细胞癌（RHCC）患者的生存和转移。

著录项

期刊名称 other
作者
Wenzhe Fan; Yingqiang Zhang; Yu Wang; Xuehua Yao; Jianyong Yang; Jiaping Li;
展开▼
作者单位

展开▼
年(卷),期 -1(10),3
年度 -1
页码 e0119312
总页数 14
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib [J] . Lei Zhang, Zhi-Ping Yan, Zhong-Heng Hou, Frontiers in Molecular Biosciences . 2021,第a期

机译：中性粒细胞到淋巴细胞和血小板到淋巴细胞比率作为患者培养的常切性肝癌栓塞加索中栓塞患者的结果预测因子
2. The platelet-to-lymphocyte ratio predicts poor survival in patients with huge hepatocellular carcinoma that received transarterial chemoembolization [J] . Xue Tong-Chun, Jia Qing-An, Ge Ning-Ling, Tumour biology : . 2015,第8期

机译：血小板与淋巴细胞的比值预示接受经大动脉化疗栓塞的巨大肝细胞癌患者的生存率较差
3. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization. [J] . Huang ZL, Luo J, Chen MS, Journal of vascular and interventional radiology: JVIR . 2011,第5期

机译：血液中性粒细胞与淋巴细胞的比率可预测无法切除的肝细胞癌患者经动脉化疗栓塞的生存率。
4. Improved quantitative contrast-enhanced ultrasound imaging of hepatocellular carcinoma response to transarterial chemoembolization [C] . Ipek Oezdemir, Collette Shaw, John R. Eisenbrey, IEEE International Symposium on Biomedical Imaging . 2019

机译：改进的肝细胞癌对经动脉化疗栓塞反应的定量对比增强超声成像
5. Sesquiterpene drugs as potential treatment for hepatocellular carcinoma (HCC): Preclinical evaluation of parthenolide administered via transarterial chemoembolization in a rat HCC tumor model. [D] . Chen, Zheng. 2016

机译：倍半萜类药物可作为肝细胞癌（HCC）的潜在治疗方法：在大鼠HCC肿瘤模型中，通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
6. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib [O] . Lei Zhang, Zhi-Ping Yan, Zhong-Heng Hou, 2021

机译：中性粒细胞到淋巴细胞和血小板到淋巴细胞比例作为患有常规化疗栓塞和索拉非尼栓塞的不可切除的肝细胞癌的患者的预测因子
7. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization. [O] . Wenzhe Fan, Yingqiang Zhang, Yu Wang, 2015

机译：中性粒细胞 - 淋巴细胞和血小板 - 淋巴细胞比率作为经动脉化疗栓塞后复发性肝细胞癌存活和转移的预测因子。

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Survival and Metastasis for Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅